Works matching IS 00218820 AND DT 2024 AND VI 77 AND IP 2

Results: 10

TNF-α-induced down-regulation of type I interferon receptor contributes to acquired resistance of cervical squamous cancer to Cisplatin.

Published in:

Journal of Antibiotics, 2024, v. 77, n. 2, p. 102, doi. 10.1038/s41429-023-00686-z

By:

Yu, Yani;
Yu, Jia;
Cui, Xiaorong;
Sun, Xin;
Yu, Xiaohui

Publication type:

Article

Remembering Dr. Shinichi Kondo (15 June 1928–8 October 2022).

Published in:

2024

By:

Ajito, Keiichi

Publication type:

Editorial

Retraction Note: Molecular docking simulation, drug-likeness assessment, and pharmacokinetic study of some cephalosporin analogues against a penicillin-binding protein of Salmonella typhimurium.

Published in:

Journal of Antibiotics, 2024, v. 77, n. 2, p. 128, doi. 10.1038/s41429-023-00684-1

By:

Ameji, Philip John;
Uzairu, Adamu;
Shallangwa, Gideon Adamu;
Uba, Sani

Publication type:

Article

Chromatin-modifying protein 4C (CHMP4C) affects breast cancer cell growth and doxorubicin resistance as a potential breast cancer therapeutic target.

Published in:

Journal of Antibiotics, 2024, v. 77, n. 2, p. 93, doi. 10.1038/s41429-023-00683-2

By:

Jin, Xiaoyan;
Wang, Jian;
Wang, Zhengyi;
Pang, Wenyang;
Chen, Yong;
Yang, Li

Publication type:

Article

Author Index for Volume 76.

Published in:: Journal of Antibiotics, 2024, v. 77, n. 2, p. 129, doi. 10.1038/s41429-023-00682-3
Publication type:: Article

Anti-microbial efficacy of l-glutaminase (EC 3.5.1.2) against multidrug-resistant Pseudomonas aeruginosa infection.

Published in:

Journal of Antibiotics, 2024, v. 77, n. 2, p. 111, doi. 10.1038/s41429-023-00678-z

By:

Mahdi, Likaa H.;
Hasoon, Buthenia A.;
Sulaiman, Ghassan M.;
Mohammed, Hamdoon A.;
Jawad, Kareem H.;
Al-Dulimi, Ali G.;
Essa, Rajwa H.;
Albukhaty, Salim;
Khan, Riaz

Publication type:

Article

Substance Index for Volumne 76.

Published in:: Journal of Antibiotics, 2024, v. 77, n. 2, p. 133, doi. 10.1038/s41429-023-00676-1
Publication type:: Article

Catenulopyrizomicins, new anti-Hepatitis B virus compounds, from the rare actinomycete Catenuloplanes sp. MM782L-181F7.

Published in:

Journal of Antibiotics, 2024, v. 77, n. 2, p. 85, doi. 10.1038/s41429-023-00681-4

By:

Yamasaki, Manabu;
Sawa, Ryuichi;
Muramatsu, Hideyuki;
Yamamoto, Yui;
Umekita, Maya;
Kubota, Yumiko;
Kanegae, Yumi;
Igarashi, Masayuki

Publication type:

Article

Antimicrobial resistance rates of urogenital Mycoplasma hominis and Ureaplasma species before and during the COVID-19 pandemic: results from a Greek survey, 2014 to 2022.

Published in:

Journal of Antibiotics, 2024, v. 77, n. 2, p. 120, doi. 10.1038/s41429-023-00680-5

By:

Akinosoglou, Karolina;
Tsiakalos, Aristotelis;
Dimopoulou, Ioanna D.;
Schinas, Georgios;
Polyzou, Eleni;
Kourea-Kremastinou, Jenny;
Pitiriga, Vassiliki C.

Publication type:

Article

Two new adenopeptins B and C inhibit sphere formation of pancreatic cancer cells.

Published in:

Journal of Antibiotics, 2024, v. 77, n. 2, p. 73, doi. 10.1038/s41429-023-00679-y

By:

Tatsuda, Daisuke;
Amemiya, Masahide;
Nosaka, Chisato;
Sawa, Ryuichi;
Muramatsu, Hideyuki;
Igarashi, Masayuki;
Yoshida, Junjiro;
Ohishi, Tomokazu;
Kawada, Manabu

Publication type:

Article